HDAC Inhibitor
Showing 1 - 25 of 7,551
Melanoma, Skin Cancer Trial in Tampa (Panobinostat, Ipilimumab)
Completed
- Melanoma
- Skin Cancer
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 18, 2023
Peripheral T-cell Lymphoma Trial in Shanghai (PD-1 antibody+ HDAC inhibitor)
Recruiting
- Peripheral T-cell Lymphoma
- PD-1 antibody+ HDAC inhibitor
-
Shanghai, Shanghai, ChinaDongmei Ji
Dec 3, 2021
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Buffalo, Rochester
Terminated
- Clear Cell Renal Cell Carcinoma
- +3 more
- panobinostat
- +7 more
-
Buffalo, New York
- +1 more
Aug 11, 2022
Hodgkin's Lymphoma Trial in Milan (histone deacetylase inhibitor (ITF2357))
Terminated
- Hodgkin's Lymphoma
- histone deacetylase inhibitor (ITF2357)
-
Milan, ItalyIstituto Nazionale per lo studio e la cura dei Tumori
Jan 18, 2022
Circulating Tumor DNA-Guided Late-Line Treatment in Late-Stage
Completed
- Metastatic Breast Cancer
- +2 more
- Control group
- Case group
- (no location specified)
Jun 16, 2022
Metastatic Colorectal Cancer Trial in Australia (Sodium Valproate, Panitumumab, Cetuximab)
Recruiting
- Metastatic Colorectal Cancer
- Sodium Valproate
- +2 more
-
Saint Leonards, New South Wales, Australia
- +8 more
Jan 22, 2023
Recurrent Plasma Cell Myeloma Trial in Columbus (Dexamethasone, HDAC Inhibitor AR-42, Laboratory Biomarker Analysis)
Completed
- Recurrent Plasma Cell Myeloma
- Dexamethasone
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Jun 10, 2021
Malignant Solid Tumour Trial in San Antonio (Hydroxychloroquine, Vorinostat)
Active, not recruiting
- Malignant Solid Tumour
-
San Antonio, TexasCancer Therapy & Research Center University of Texas Health Scie
Dec 13, 2021
Advanced Lymphoma, Advanced Malignant Solid Tumor, Advanced Pancreatic Carcinoma Trial in New Haven (BET Bromodomain Inhibitor
Recruiting
- Advanced Lymphoma
- +13 more
- BET Bromodomain Inhibitor ZEN-3694
- +2 more
-
New Haven, ConnecticutYale University Cancer Center LAO
Jun 29, 2022
Metastatic Breast Cancer, Recurrent Ovarian Carcinoma Trial in Salt Lake City, Fairfax (Ribociclib, Belinostat)
Recruiting
- Metastatic Breast Cancer
- Recurrent Ovarian Carcinoma
-
Salt Lake City, Utah
- +1 more
May 3, 2022
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +20 more
- panobinostat
- +6 more
-
Scottsdale, Arizona
- +1 more
May 6, 2022
Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States
Active, not recruiting
- Clear Cell Renal Cell Carcinoma
- +3 more
- Aldesleukin
- +6 more
-
Los Angeles, California
- +3 more
Nov 16, 2022
Advanced Cancers Trial in Houston (Hydroxychloroquine, Sirolimus, Vorinostat)
Completed
- Advanced Cancers
- Hydroxychloroquine
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 3, 2021
Relapsed or Refractory Multiple Myeloma Trial (Vorinostat, Bortezomib, Dexamethasone)
Completed
- Relapsed or Refractory Multiple Myeloma
- Vorinostat
- +2 more
- (no location specified)
Mar 5, 2021
Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in United States (JBI-802)
Recruiting
- Locally Advanced Solid Tumor
- Metastatic Solid Tumor
-
Denver, Colorado
- +3 more
Aug 19, 2022
Extensive Stage Lung Small Cell Carcinoma, Malignant Solid Tumor, Metastatic Malignant Tumor in the Brain Trial in United States
Active, not recruiting
- Extensive Stage Lung Small Cell Carcinoma
- +2 more
- Atezolizumab
- +3 more
-
New York, New York
- +4 more
Jul 16, 2022
Breast Adenocarcinoma, Invasive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States (drug, biological, other)
Active, not recruiting
- Breast Adenocarcinoma
- +9 more
- Entinostat
- +4 more
-
Duarte, California
- +4 more
Jul 16, 2022
Human Immunodeficiency Virus (HIV) Trial in New York, Aarhus, Cologne (3BNC117, Romidepsin)
Completed
- Human Immunodeficiency Virus (HIV)
-
New York, New York
- +2 more
Feb 3, 2021
Biliary Tract Cancer Trial in London (KA2507)
Withdrawn
- Biliary Tract Cancer
-
London, United KingdomCancer Research UK and UCL Cancer Trials Centre
Jan 30, 2021
Cutaneous T-Cell Lymphoma Trial in United States (Panobinostat)
Terminated
- Cutaneous T-Cell Lymphoma
-
Birmingham, Alabama
- +17 more
Aug 16, 2021
Melanoma Trial in New York (Mocetinostat Induction Phase + Ipilimumab + Nivolumab, Mocetinostat Maintenance Phase + Ipilimumab +
Terminated
- Melanoma
- Mocetinostat Induction Phase + Ipilimumab + Nivolumab
- Mocetinostat Maintenance Phase + Ipilimumab + Nivolumab
-
New York, New YorkNew York University School of Medicine
May 19, 2020